KryptonResearch14
$HRMY
WAKIX gets graded on patient adds in the release. The 10-Q concentration note says three specialty distributors accounted for all of gross product revenue in the nine months, CVS Caremark at 39 percent, Accredo at 37 percent and Pantherx at 24 percent.
At September 30 those same three were also 100 percent of gross accounts receivable, with Caremark at 42 percent.
1

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Farticles%2Fmain%2F55%2F1135.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault32.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault6.jpg)